摘要
目的:探讨蒙脱石散联合双歧杆菌乳杆菌三联活菌片治疗小儿急性腹泻的临床疗效。方法选取我院自2013年2月~2014年2月接收的80例小儿急性腹泻患儿,随机分为观察组和对照组,每组40例,对照组行单纯蒙脱石散治疗,观察组则行蒙脱石散联合双歧杆菌乳杆菌三联活菌片治疗,比较两组患儿的临床疗效。结果两组患儿治疗总有效率、退热时间、呕吐消失时间、腹痛消失时间、大便正常时间等比较均有显著性差异(P <0.05)。结论给予急性腹泻患儿蒙脱石散联合双歧杆菌乳杆菌三联活菌片治疗可有效的提高治疗效果,改善患儿临床症状。
Objective Clinical study of Montmorillonite powder with Live Combined Bifidobacterium and Lactobacillus Tablets in treatment of acute diarrhea in children. Methods Select children from acute diarrhea 80 cases in our hospital from January 2013 to January 2014, randomly into observation group and control group, Each group had 40 cases. The control group alone montmorillonite powder treatment, observation group application montmorillonite powder and Live Combined Bifidobacterium and Lactobacillus Tablets combination therapy. Therapeutic effects were compared. Results The total efficiency of the two groups of children, cooling time, vomiting disappearance time, abdominal pain time, stool normal time were significant differences (P〈0.05). Conclusion Montmorillonite powder with Live Combined Bifidobacterium and Lactobacillus Tablets in the treatment of children with acute diarrheacan effectively improve the treatment effect, improve the clinical symptoms in children, has a high application value, and can be popularized and applied.
出处
《中国继续医学教育》
2014年第8期140-141,共2页
China Continuing Medical Education
关键词
蒙脱石散
双歧杆菌乳杆菌三联活菌片
小儿急性腹泻
Montmorillonite powder Live Combined Bifidobacterium and Lactobacillus Tablets Children with acute diarrhea